INS and diabetes mellitus: “Real-time continuous glucose monitoring should be offered for diabetes management in adults with diabetes on multiple daily injections or continuous subcutaneous insulin infusion who are capable of using the devices safely,” supported by randomized controlled trials with a level of evidence A (21).